Skip to main content
Premium Trial:

Request an Annual Quote

New Institutions Gain Access to Sophia Genetics Technology

NEW YORK (GenomeWeb) – Sophia Genetics today said that it is providing 11 new institutions access to its DNA sequencing analysis technology. 

The 11 European organizations will use Sophia's technology, including the Sophia Data Driven Medicine (DDM) Platform, to provide genetic testing to their patients, the Swiss firm said. 

DDM is a software-as-a-service platform for routine diagnostic testing that integrates modules for clinical next-generation sequencing data analysis, according to Sophia's website. The core module, Sophia Clinical Genomics, processes and analyzes data from multiple gene panels, as well as exomes and genomes from raw patient DNA sequence data. DNA sequence files are automatically uploaded and processed via algorithms and machine learning. 

The institutions are SW Thames Molecular Genetics Diagnostic Laboratory, St. Georges University Hospital of London; Gemelli Hospital, Rome; Prenatal – MVZ Nuremberg, Germany; Hospital Vall d'Hebron, Spain; and University Hospital Donostia, Spain. 

Also gaining access to Sophia's technology are Ramon y Cajal Hospital, Spain; Hospital de Sant Pau, Spain; Cruces Hospital Vizcaya, Spain; University Institute of Clinical Research, Montpellier, France; Tenon Hospital, France; and University Hospital in Limoges, France.